XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE FINANCIAL INSTRUMENTS
 6 Months Ended
Jan. 01, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS Derivative Financial Instruments
As of January 1, 2022, the Company had outstanding foreign currency forward contracts with a total notional amount of $13.9 million. The maturity dates for these contracts extend through June 2022. For the three months ended January 1, 2022, the Company did not enter into any foreign currency forward contracts and settled $5.1 million of contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $6.3 million of contracts.
For the six months ended January 1, 2022, the Company entered into $13.9 million of foreign currency forward contracts and settled $10.6 million of such contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $13.0 million of such contracts.
As of January 1, 2022, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):
Quarter EndingNotional Contracts in MXNNotional Contracts in USDEstimated Fair Value
April 2, 2022$149,893 $7,224 $35 
July 2, 2022$141,493 $6,726 $7 
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. On the date of termination this interest rate swap was in a liability position of $148,400, which will be amortized to interest expense over the original term of the swap.
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. On the date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap.
The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of January 1, 2022 and July 3, 2021 (in thousands):
January 1, 2022July 3, 2021
Derivatives Designated as Hedging InstrumentsBalance Sheet LocationFair ValueFair Value
Foreign currency forward contractsOther current assets$43 $3,614 
Foreign currency forward contractsOther current liabilities$(1)$— 

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended January 1, 2022 and December 26, 2020, respectively (in thousands):
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
October 2, 2021		Effective
Portion
Recorded In
AOCI		Effective Portion
Reclassified From
AOCI Into
Income		AOCI Balance
as of
January 1, 2022
Forward contractsCost of sales$1,115 $338 $(1,498)$(45)
Interest rate swapInterest expense(574)— 76 (498)
Total$541 $338 $(1,422)$(543)
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
September 26, 2020		Effective
Portion
Recorded In
AOCI		Effective Portion
Reclassified From
AOCI Into
Income		AOCI Balance
as of
December 26, 2020
Forward contractsCost of sales$643 $2,958 $(108)$3,493 
Interest rate swapInterest expense(875)— 76 (799)
Total$(232)$2,958 $(32)$2,694 

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the six months ended January 1, 2022 and December 26, 2020, respectively (in thousands):
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
July 3, 2021		Effective
Portion
Recorded In
AOCI		Effective Portion
Reclassified From
AOCI Into
Income		AOCI Balance
as of
January 1, 2022
Forward contractsCost of sales$2,721 $562 $(3,328)$(45)
Interest rate swapInterest expense(649)— 151 (498)
Total$2,072 $562 $(3,177)$(543)
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
June 27, 2020		Effective
Portion
Recorded In
AOCI		Effective Portion
Reclassified From
AOCI Into
Income		AOCI Balance
as of
December 26, 2020
Forward contractsCost of sales$(759)$4,001 $251 $3,493 
Interest rate swapInterest expense(741)(223)165 (799)
Total$(1,500)$3,778 $416 $2,694 
As of January 1, 2022, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $33,000. As of January 1, 2022, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.